Abbott Labs Files Q1 2025 10-Q
Ticker: ABT · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1800
| Field | Detail |
|---|---|
| Company | Abbott Laboratories (ABT) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Abbott Labs dropped its Q1 2025 10-Q. Check financials.
AI Summary
Abbott Laboratories filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position, including its fiscal year end of December 31st. Specific financial figures and operational details for the first quarter of 2025 are presented.
Why It Matters
This filing provides investors and analysts with the latest financial data for Abbott Laboratories, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 2025-03-31 — Period End Date (Quarterly reporting period)
- 2025-01-01 — Period Start Date (Quarterly reporting period)
- 2024-03-31 — Prior Year Quarter End (Comparison period)
Key Players & Entities
- ABBOTT LABORATORIES (company) — Filer
- 0001628280-25-021090 (filing_id) — Accession Number
- 20250331 (date) — Period of Report
- 20250430 (date) — Filed as of Date
- 100 ABBOTT PARK ROAD (address) — Business Address
- IL (state) — State of Incorporation
- 1231 (date) — Fiscal Year End
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on April 30, 2025.
What is Abbott Laboratories' fiscal year end?
Abbott Laboratories' fiscal year ends on December 31st.
What is the company's primary business address?
The company's primary business address is 100 Abbott Park Road, Abbott Park, IL 60064-3500.
What is the SIC code for Abbott Laboratories?
The Standard Industrial Classification (SIC) code for Abbott Laboratories is 2834, Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding ABBOTT LABORATORIES (ABT).